Philips in deals with U.S. hospitals on use of its gene data platform for cancer research

AMSTERDAM (Reuters) - Dutch healthcare technology company Philips said Thursday it had reached deals with New York's Memorial Sloan Kettering Cancer Center (MSK) and Utah-based Intermountain Healthcare for them to use its genomics platform for cancer research and treatment.